239066-82-1

Basic information

• Product Name: 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline
• Synonyms: 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline
• CAS NO: 239066-82-1
• Molecular Weight: 476.413
• Mol File: 239066-82-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline(239066-82-1)
• EPA Substance Registry System: 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline(239066-82-1)

Safety Data

• Hazardous Substances Data: 239066-82-1(Hazardous Substances Data)

Upstream product

• 364629-87-8 (3-bromo-5-methylphenyl)magnesium bromide 
• 239071-00-2 5,10-dimethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene 
• 6942-36-5 methyl 2-bromo-5-nitrobenzoate 
• 23112-96-1 (2,6-dimethoxyphenyl)boronic acid 
• 239070-96-3 1-methoxy-8-amino-6H-dibenzo[b,d]pyran-6-one 
• 239070-99-6 10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-ol 
• 239070-97-4 2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline 
• 239070-93-0 methyl 2',6'-dimethoxy-4-nitro-1,1'-biphenyl-2-carboxylate 
• 239070-94-1 1-hydroxy-8-nitro-6H-benzo[c]chromen-6-one 
• 239070-95-2 1-methoxy-8-nitro-6H-dibenzo[b,d]pyran-6-one 

Downstream Products

• 239066-87-6 5-[3-(2-furanyl)-5-methylphenyl]-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline 

Relevant articles and documents

Glucocortiocoid-selective antinflammatory agents

Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.